2017-03-20,Look for Clovis Oncology to Resume Its Advance
2017-03-15,Notable Wednesday Option Activity: CLVS, KMG, NYLD
2017-03-15,Goldman Sachs Raises Clovis Oncology Price Target to $75
2017-03-15,6 Stocks Trending Up With Major Volume
2017-03-14,AstraZeneca Takes PARP Inhibitor Fight to Rival Tesaro with Strong Ovarian Cancer Study Results
2017-03-12,Clovis Oncology Presents New Data From Phase 2 Studies Of Rucaparib In Advanced Ovarian Cancer At 2017 SGO Annual Meeting On Women's Cancer
2017-02-22,Clovis Oncology Announces 2016 Operating Results
2017-02-18,Johnson & Weaver, LLP Announces Investigations Of Clovis Oncology, Inc., USANA Health Sciences, Inc., Anthera Pharmaceuticals, Inc., And PixarBio Corporation
2017-02-17,Clovis, Tesaro Soar on Astrazeneca Phase Three News
2017-02-13,Morgan Stanley, Twitter, Tesaro: Doug Kass' Views
2017-02-10,Clovis Oncology Inc Reaches Analyst Target Price
2017-02-09,Clovis Oncology To Announce Fourth Quarter/Year-End 2016 Financial Results And Host Webcast Conference Call On February 22
2017-02-08,Biotech Tesaro Climbs on Takeout Reports
2017-02-01,Clovis Oncology And Strata Oncology Announce Collaboration To Accelerate Enrollment In Rucaparib Prostate Cancer Development Program
2017-01-10,4 Biotech Names That Could Be M&amp;A Targets
2017-01-09,Clovis Oncology To Present At The 35th Annual J.P. Morgan Healthcare Conference
2017-01-04,Clovis Oncology Announces Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock
2017-01-03,Clovis Oncology Announces Upsizing And Pricing Of Public Offering Of Common Stock
2017-01-03,Clovis Oncology Announces Proposed Offering Of Common Stock
2017-01-03,17 Thoughts on Biotech Stocks to Kick Off 2017
2016-12-19,Noteworthy Monday Option Activity: CLVS, GTY, BEAT
2016-12-19,Big-Cap Tech Names, Biotechs, Oils Lifting Market
2016-12-19,Clovis Oncology Announces FDA Accelerated Approval Of RUBRACA™ (rucaparib) For The Monotherapy Treatment Of Advanced Ovarian Cancer In Women With Deleterious Germline Or Somatic BRCA Mutations Treated With Two Or More Chemotherapies
2016-12-19,Clovis Oncology Gets FDA Approval for New Ovarian Cancer Drug
2016-12-19,Clovis Oncology Secures FDA Approval for New Ovarian Cancer Drug
2016-12-01,Lifshitz & Miller Law Firm Announces Investigation Of Adeptus Health Inc., Avid Technology, Inc., Cempra, Inc., Clovis Oncology, Inc., Impax Laboratories, Inc., Ligand Pharmaceuticals Incorporated, Pattern Energy Group Inc. And Kandi Technologies Group, Inc.
2016-11-30,Newman Ferrara LLP Announces Corporate Governance Investigation Of Clovis Oncology Inc.
2016-11-22,First Week of July 2017 Options Trading For Clovis Oncology (CLVS)
2016-11-17,Robbins Arroyo LLP: Clovis Oncology, Inc. (CLVS) Misled Shareholders According To A Recently Filed Lawsuit
2016-11-14,CLVS Crosses Above Average Analyst Target
2016-11-03,Clovis Oncology Announces Q3 2016 Operating Results And Corporate Update
2016-11-01,'Mad Money' Lightning Round: No Sunshine for Solar Plays
2016-10-31,Jim Cramer's 'Mad Money' Recap: Earnings, Politics and Uncertainty Stir the Pot
2016-10-31,Research Reports On Biotech Equities -- Mast Therapeutics, Array BioPharma, Galena Biopharma, And Clovis Oncology
2016-10-31,Clovis Oncology To Present At The 2016 Credit Suisse Healthcare Conference
2016-10-27,Clovis Oncology To Announce Third Quarter 2016 Financial Results And Host Webcast Conference Call On November 3
2016-10-25,After FDA Approval, Merck Posts Better-Than-Expected Earnings
2016-10-19,'Mad Money' Lightning Round: People Keep Underrating Cable Stocks
2016-10-18,Jim Cramer's 'Mad Money' Recap: These Companies Have Changed How We Live
2016-10-08,How to Anticipate When a Positive Stock Trend Is About to Reverse
2016-10-08,Tesaro Drug Delays Recurrence of Ovarian Cancer, New Clinical Trial Shows
2016-10-07,Clovis Oncology (CLVS) Stock Tumbles on Trial Update, SunTrust Bullish
2016-10-07,Clovis Falls on Fears Ovarian Cancer Drug Inferior to Competition
2016-10-07,Clovis Oncology Presents Efficacy And Safety Data From New Drug Application (NDA) Population For Rucaparib In The Treatment Of Advanced Mutant BRCA Ovarian Cancer At 2016 ESMO Congress
2016-10-04,Investor's Guide to This Week's Clovis, Tesaro Ovarian Cancer Drug Updates
2016-09-29,Jim Cramer's 'Mad Money' Recap: Blame the Banks for Today's Market Drop
2016-09-28,Clovis Oncology Announces Rucaparib Data Presentations At ESMO 2016 Congress
2016-09-23,Takeover Chatter Around Clovis May Be Overdone
2016-09-22,'Mad Money' Lightning Round: Broadcom Is Going to $200
2016-09-21,Jim Cramer's 'Mad Money' Recap: Just Buy What's Working
2016-09-21,Here's Why Shares of Clovis Oncology Are Higher Wednesday
2016-09-21,Clovis Oncology Charts Suggest Aggressive Buying
2016-09-21,Clovis Oncology (CLVS) Stock Advances, Credit Suisse Upgrades
2016-09-21,Morning Movers: MYL, XOM, MSFT, GIS, CLVS
2016-09-21,Analysts' Actions -- Clovis, Altria, Sketchers, Wells Fargo and More
2016-09-08,Here's A Reason Why Clovis Oncology (CLVS) Stock Is Surging Today
2016-08-31,Here's a Reason Why Clovis Oncology (CLVS) Stock Is Gaining Today
2016-08-26,'Mad Money' Lightning Round: I Can't Recommend Gilead
2016-08-25,Jim Cramer's 'Mad Money' Recap: Markets Make This Economy, Not the Fed
2016-08-24,7 Stocks Trading on Big Volume -- and What to Do With Them Now
2016-08-24,CLVS Crosses Above Average Analyst Target
2016-08-23,Here's a Reason Why Clovis Oncology (CLVS) Stock Climbed Today
2016-08-23,FDA Accepts Clovis Oncology's New Drug Application For Rucaparib For Priority Review For The Treatment Of Advanced Mutant BRCA Ovarian Cancer
2016-08-08,Clovis Oncology Announces Q2 2016 Operating Results And Corporate Update
2016-07-26,Clovis Oncology To Announce Second Quarter 2016 Financial Results And Host Webcast Conference Call On August 8
2016-06-29,16 Biopharma Companies Besides Medivation That Are Attractive Targets
2016-06-06,Clovis Oncology Presents Data From Phase 2 Studies Of Rucaparib In Advanced Ovarian Cancer And Pancreatic Cancer At 2016 ASCO Annual Meeting
2016-05-19,Clovis Oncology Announces Data Presentations At 2016 ASCO Annual Meeting
2016-05-12,Clovis Oncology Becomes Oversold (CLVS)
2016-05-11,The Shuman Law Firm Investigates Clovis Oncology, Inc.
2016-05-05,Clovis Oncology Announces Q1 2016 Operating Results And Corporate Update
2016-04-26,Clovis Oncology To Announce First Quarter 2016 Financial Results And Host Webcast Conference Call On May 5
2016-04-13,Why Clovis Oncology (CLVS) Stock is Tumbling Today
2016-04-12,Clovis Oncology Provides Update On FDA Oncologic Drugs Advisory Committee Meeting To Review Rociletinib For Treatment Of Advanced T790M-Positive Mutant Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer
2016-04-12,Clovis Lung Cancer Drug Trashed at FDA Panel, CEO Exit Next?
2016-04-12,Trading Of Clovis Oncology, Inc. Common Stock Halted
2016-04-11,Why Clovis Oncology (CLVS) Stock is Dropping Today
2016-04-08,Clovis Smart Move is to Drop Damaged Lung Cancer Drug Altogether
2016-04-08,FDA Posts Briefing Documents For Advisory Committee Meeting To Review Clovis Oncology's Rociletinib For Treatment Of Advanced T790M-Positive Mutant Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer
2016-03-22,First Week of May 20th Options Trading For Clovis Oncology (CLVS)
2016-02-25,Clovis Oncology Announces 2015 Operating Results
2016-02-16,Clovis Oncology To Announce Fourth Quarter/Year-End 2015 Financial Results And Host Webcast Conference Call On February 25
2016-02-12,Clovis Oncology Announces Rociletinib New Drug Application Scheduled For Presentation At Upcoming FDA Oncologic Drugs Advisory Committee Meeting
2016-01-27,Clovis Oncology Initiates Immunotherapy Combination Trial
2016-01-26,Clovis Oncology Becomes Oversold (CLVS)
2016-01-25,Clovis Oncology Appoints Dale Hooks As Chief Commercial Officer
2016-01-18,UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders Of Clovis Oncology, Inc. Of Filing Of Class Action Lawsuit And Lead Plaintiff Deadline Of January 18, 2016 - CLVS
2016-01-15,SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of Clovis Oncology, Inc. - CLVS
2016-01-12,UPCOMING DEADLINE ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Clovis Oncology, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2016-01-12,INVESTOR ALERT: The Law Offices Of Vincent Wong Remind Investors Of Class Action Involving Clovis Oncology, Inc. And A Lead Plaintiff Deadline Of January 19, 2016
2016-01-08,Lifshitz & Miller Law Firm Announces Investigation Of Chipotle Mexican Grill, Inc., Clovis Oncology, Inc., Consolidated Tomoka Land Co., Marchex, Inc., Multi-Color Corp., SunEdison, Inc., And Vital Therapies, Inc.
2016-01-08,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Clovis Oncology, Inc. Of Filing Of Class Action Lawsuit And Lead Plaintiff Deadline Of January 18, 2016 - CLVS
2016-01-08,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Clovis Oncology, Inc. Of Class Action Lawsuit And Upcoming Deadline - CLVS
2016-01-07,Levi & Korsinsky, LLP Notifies Shareholders Of Clovis Oncology, Inc. Of Filing Of Class Action Lawsuit And Lead Plaintiff Deadline Of January 18, 2016
2016-01-06,Clovis Oncology To Present At The 34th Annual J.P. Morgan Healthcare Conference
2015-12-19,The Naughty List: Finalists for Worst Biopharma CEO of 2015
2015-12-16,CLVS Investors: GPM Reminds Investors Of The Deadline In The Securities Class Action On Behalf Of Clovis Oncology, Inc. Investors
2015-12-15,Clovis Oncology Receives Notification Of PDUFA Extension For Rociletinib
2015-12-11,Investor Deadline Alert: Law Offices Of Howard G. Smith Reminds Clovis Oncology, Inc. Investors Of Upcoming Lead Plaintiff Deadline
2015-12-10,Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Clovis Oncology, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2015-12-08,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Clovis Oncology, Inc. - CLVS
2015-12-08,IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Clovis Oncology, Inc. And Encourages Investors To Contact The Firm Before The Deadline
2015-12-04,CLVS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Clovis Oncology, Inc.
2015-12-02,Clovis Oncology, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors
2015-12-02,STOCK ALERT: Rosen Law Firm Reminds Clovis Oncology, Inc. Investors Of Important Deadline In Class Action Filed By Firm
2015-12-02,Shareholder Class Action Filed Against Clovis Oncology, Inc. - CLVS
2015-12-02,Clovis Oncology, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches Of Fiduciary Duty
2015-11-30,Wolf Popper LLP Announces Investigation On Behalf Of Investors In Clovis Oncology, Inc.
2015-11-23,Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Clovis Oncology, Inc.
2015-11-23,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors Of Class Action Against Clovis Oncology, Inc. And Lead Plaintiff Deadline
2015-11-21,Clovis Blowup Conjures Bad Biotech Memories of ImClone Darkness
2015-11-20,Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Clovis Oncology, Inc.
2015-11-20,EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Clovis Oncology, Inc.
2015-11-19,INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud By Clovis Oncology, Inc. And Certain Officers And Directors
2015-11-17,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud By Clovis Oncology, Inc. And Certain Officers And Directors -- CLVS
2015-11-17,SHAREHOLDER NOTICE: Goldberg Law PC Announces An Ongoing Investigation Of Claims Against Clovis Oncology, Inc. And Encourages Shareholders To Contact The Firm
2015-11-16,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Clovis Oncology, Inc.
2015-11-16,Market News: Range Resources, Steadymed, Clovis Oncology
2015-11-16,Stocks Rally to Close Higher After Choppy Start
2015-11-16,EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Clovis Oncology, Inc. - CLVS
2015-11-16,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud By Clovis Oncology, Inc. And Certain Officers And Directors
2015-11-16,Stocks Are Trading Near Session Highs
2015-11-16,Clovis Oncology (CLVS) Stock Plunging On Anticipated Delay in FDA Drug Approval
2015-11-16,Clovis Craters on Lung Cancer Drug-Review Delay
2015-11-16,Clovis Oncology Announces Regulatory Update For Rociletinib NDA Filing
2015-11-05,Clovis Oncology Announces Third Quarter 2015 Operating Results
2015-11-03,Clovis Oncology To Present At The 2015 Credit Suisse Healthcare Conference
2015-10-22,Clovis Oncology To Announce Third Quarter 2015 Financial Results And Host Webcast Conference Call On November 5
2015-09-29,Clovis Oncology Announces U.S. And E.U. Regulatory Milestones For Rociletinib In The Treatment Of Advanced EGFR-Mutant T790M+ Non-Small Cell Lung Cancer
2015-09-23,Clovis Oncology Announces Data Presentations At 2015 European Cancer Congress
2015-09-10,Clovis Oncology To Present At The Morgan Stanley Global Healthcare Conference 2015
2015-09-04,Clovis Oncology Announces Data Presentations At 16th World Conference On Lung Cancer
2015-08-11,Clovis Oncology Enters Into Clinical Trial Collaboration
2015-08-06,Clovis Oncology Announces Second Quarter 2015 Operating Results
2015-08-03,Clovis Oncology Completes U.S. And E.U. Regulatory Submissions For Rociletinib For The Treatment Of Advanced EGFR-Mutant T790M+ Non-small Cell Lung Cancer
2015-07-23,Clovis Oncology To Announce Second Quarter 2015 Financial Results And Host Webcast Conference Call On August 6
2015-07-10,Clovis Oncology Announces Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock
2015-07-08,Clovis Oncology Announces Pricing Of Public Offering Of Common Stock
2015-07-07,Clovis Oncology Announces Proposed Offering Of Common Stock
2015-07-02,Fly Watch: Biotech Sector Events To Watch For This Summer
2015-07-01,Clovis Oncology Initiates Rolling NDA Submission To The FDA For Rociletinib In The Treatment Of Advanced EGFR-Mutant Non-small Cell Lung Cancer
2015-06-22,Clovis Oncology Appoints Dr. Lindsey Rolfe As Chief Medical Officer
2015-06-01,ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
2015-06-01,Clovis Wins One ASCO '15 Battle, Loses Another, Against Rival AstraZeneca
2015-05-31,Clovis Oncology's Rociletinib (CO-1686) Phase 2 Study Results Demonstrate Consistent And Promising Clinical Activity And Disease Control In Very Advanced Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
2015-05-30,Clovis Oncology's Phase 2 Studies Of Rucaparib In Ovarian Cancer Demonstrate Highly Compelling Clinical Activity, In Both BRCA-mutant And BRCA-like Patients, Together Comprising Approximately 60 Percent Of Patients
2015-05-29,Fly Watch: Several Names That May Move Following ASCO Meeting
2015-05-22,Biotech Stock Mailbag: ASCO Preview, CAR-T stocks, MannKind, Hate Mail!
2015-05-13,Clovis Oncology Announces Data Presentations At 2015 ASCO Annual Meeting
2015-05-13,Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts
2015-05-06,Clovis Oncology Announces First Quarter 2015 Operating Results
2015-04-23,Clovis Oncology To Announce First Quarter 2015 Financial Results And Host Webcast Conference Call On May 6
2015-04-13,Clovis Oncology (CLVS) Stock Spikes Today on Analyst Upgrade
2015-04-06,Clovis Oncology (CLVS) Stock Gains in After-Hours Trading After 'Breakthrough Therapy' Designation
2015-04-06,Clovis Oncology Receives Breakthrough Therapy Designation For Rucaparib For Monotherapy Treatment Of Advanced Ovarian Cancer In Patients With BRCA-mutated Tumors (Inclusive Of Both Germline And Somatic BRCA Mutations)
2015-03-21,'Fast Money' Recap: How to Buy Into Biotech Without Going Crazy
2015-02-25,Clovis Oncology Announces 2014 Operating Results
2015-02-17,Clovis Oncology To Announce Fourth Quarter/Year-End 2014 Financial Results And Host Webcast Conference Call On February 25
2015-02-04,Clovis Oncology To Present At The 2015 Leerink Global Healthcare Conference
2015-01-13,International Tower Hill Mines Gets A John Paulson Lift?
2015-01-05,Clovis Oncology To Present At The 33rd Annual J.P. Morgan Healthcare Conference
2014-11-19,Initial Data From Ongoing Phase 2 ARIEL2 Study Of Rucaparib In Ovarian Cancer Demonstrate Encouraging Clinical Activity And Safety In Both BRCA Mutant And BRCAness Patients
2014-11-19,Clovis Lung Cancer Update Swings Momentum to Rival, Slightly
2014-11-18,Interim Data From Rociletinib (CO-1686) Phase 1/2 Study Shows Compelling And Durable Clinical Activity And Progression-free Survival (PFS) In Patients With EGFR-Mutant Non-small Cell Lung Cancer (NSCLC)
2014-11-17,Clovis Oncology Enters Into Oncology Clinical Trial Collaboration With GlaxoSmithKline
2014-11-12,Clovis Oncology Announces First Patient Enrolled In TIGER-1 Study
2014-11-06,Clovis Oncology Announces Third Quarter 2014 Operating Results
2014-11-04,Clovis Oncology To Present At The 2014 Credit Suisse Healthcare Conference
2014-11-03,Super Important Biotech and Drug Stock Events for November
2014-10-27,Short Interest In Clovis Oncology Jumps 21.4%
2014-10-24,First Week of December 20th Options Trading For Clovis Oncology (CLVS)
2014-10-23,Clovis Oncology Announces First Patient Enrolled In Lucitanib Phase 2 Study In Squamous Non-small Cell Lung Cancer
2014-10-22,Clovis Oncology To Announce Third Quarter 2014 Financial Results And Host Webcast Conference Call On November 6
2014-10-02,Three Speculative Biotech Plays
2014-09-30,3 Unusual-Volume Stocks Triggering Breakout Trades
2014-09-29,Clovis Shares Higher on Improved Outlook for Lung Cancer Drug
2014-09-28,Data From Ongoing Phase 2 Studies Of Rucaparib In Ovarian Cancer Demonstrate Safety And Clinical Activity, Validate Differentiated Strategy
2014-09-10,Clovis Oncology Announces First Patient Enrolled In Lucitanib Phase 2 Study In FGF-aberrant Advanced Breast Cancer
2014-09-09,Clovis Oncology Announces Exercise In Full By Initial Purchasers Of Their Option To Purchase An Additional $37.5 Million Aggregate Principal Amount Of The Company’s 2.50% Convertible Senior Notes Due 2021
2014-09-08,Clovis Oncology To Present At The 2014 Morgan Stanley Global Healthcare Conference
